FindTrial
Sign In

A Study on Laboratory Details and Cost of Dengue Fever

A Retrospective Study on Clinical Presentations and Cost of Illness in Patients with Dengue Fever

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/12/029749
Enrollment
218
Registered
2020-12-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B338- Other specified viral diseases

Interventions

None listed

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with dengue fever. Patients admitted in the hospital minimum of 2 days. Patients admitted in the hospital during january 2018 to december 2019.

Exclusion criteria

Exclusion criteria: Patients with incomplete records. Pregnant patients.

Design outcomes

Primary

MeasureTime frame
To estimate the cost of illness by calculating the direct medical cost of patients treated for Dengue fever. To study the different types of drug prescribed. To study the clinical presentations of the disease.Timepoint: Single Points—

Secondary

MeasureTime frame
The result of the study will highlight the economic burden on the patients suffering from the dengue . The prescription pattern will give the idea about the drug cost and trends of prescribing pattern.Timepoint: Single points—

Countries

India

Contacts

Public ContactDr Chethan Subramanya

Dept. of Pharmacy Practice, NGSM Institute of Pharmaceutical Sciences

udayv@nitte.edu.in8152977460

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026